Startup accelerator & VC Value proposition
We actively fund innovative companies within the two evolving fields of Digital technologies and Life sciences.
Seventure Partners is a long term equity investor that actively supports innovative companies aiming at generating positive impacts on Humankind, Society, Sustainability and the Planet.
With €950m net commitments under management as of the end of 2022, Seventure is a leading venture capital firm in Europe investing since 1997 in innovative businesses with high growth potential in 2 main areas: Life sciences (Biotech, Health & digital Health, Nutrition, Foodtech, Blue Economy, Aquaculture, Animal & Agriculture, Sport & Wellness ...) with a specific interest for microbiome-related innovations across Europe, Israel, Asia and North America and Digital technologies (FinTech, RetailTech etc...) in Western Europe.
Investments can range between €500k and €10m per round and up to €20m per company, from early to late stage, growth, pre-IPO and IPO.
Investments can range between €500k and €10m per round, or up to €20m per company, from early to late stage.
Seventure is a subsidiary of Natixis Global Asset Management. Natixis is the corporate investment management and financial services arm of Groupe BPCE, the second-largest French bank.
For more details: www.seventure.com
Venture Capital, Life sciences, Information and Communication Technology, Financement de l'innovation, Technologies digitales, Fintech, Microbiome, Dispositifs médicaux, Médicaments, Logiciels, Services innovants, Fonds de capital investissement, Sportech, Blue Economy, Healthtech, and AgritechOriginal language
We actively fund innovative companies within the two evolving fields of Digital technologies and Life sciences.
Seventure Partners est un investisseur de long terme qui accompagne activement en capital les entreprises innovantes visant un impact positif sur l’Homme, la Société et la Planète.
Avec 950 M€ sous gestion* à fin 2022, Seventure est un leader Européen du capital innovation et investit depuis 1997 dans des sociétés à fort potentiel de croissance évoluant dans deux principaux domaines d’activité : les Sciences de la vie (Biotechnologies, Santé & santé digitale, Nutrition, Alimentation, Nutrition, Blue Economy, Aquaculture, Animal & Agriculture, Sport & Bien-être ...) avec un intérêt particulier pour les entreprises du microbiome, dans toute l’Europe ainsi qu’en Israël, Asie et Amérique du Nord, et les Technologies digitales (FinTech, RetailTech etc...) principalement en France et en Allemagne.
Seventure accompagne le développement de sociétés depuis la création de l’entreprise (amorçage et premier tour), jusqu’à des tours de financement de capital développement (venture, growth, pre-IPO et IPO), avec des montants investis entre 500 K€ et 10 M€ par tour de financement, et jusqu’à 20 M€ par société.
Seventure Partners, partenaire actif des sociétés innovantes dans les domaines des technologies digitales et des sciences de la vie. | Seventure
Seventure Partners, partenaire actif des sociétés innovantes dans les domaines des technologies digitales et des sciences de la vie. | Seventure
https://www.seventure.fr/
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | MicrobiomePost Online Audio and Video Media | Other 8 Feb 2023 | | |
 | Labiotech.eu Online Audio and Video Media | Other 17 Nov 2022 | | |
 | POLEPHARMA healthtech, Pharmaceutical Manufacturing | Other 9 Oct 2022 | | |
 | CorWave manufacturing, deeptech, healthtech, nanotech, Medical Equipment Manufacturing | Capitalistic Partnership Event 10 Oct 2023 | | |
 | Recommerce Group consumer goods, e-commerce, transporttech, Technology, Information and Internet | Other 31 Jan 2022 | | |
 | Yucatan Press & Media Relations Consulting, martech, Public Relations and Communications Services | Other 19 Nov 2023 | | |
 | Expensya fintech, IT Services, Software Development | Not capitalistic Not partnership Event 8 Jun 2023 | | |
 | Eligo Bioscience biotech, deeptech, Biotechnology Research | Other 8 Dec 2023 | | |
 | MaaT Pharma biotech, deeptech, Biotechnology Research | Not capitalistic Partnership Not event 25 Mar 2024 | | |
 | Microbiotica biotech, deeptech, Biotechnology Research | Capitalistic Not partnership Not event 25 Sep 2022 | | |